Research and Reviews in Parkinsonism presents current information about Parkinsonism and Restless legs Syndrome related research, policy, phenomenology, literature, history, and treatment. This journal offers broad range of coverage in a wide-array of disciplines, from clinical and therapeutic aspects to understanding of molecular pathways involved in these disorders. This journal also covers the history of medicine in particular neurology, and social as well as psychological aspects of these disorders.
The journal provides a forum for international debate on various aspects of Parkinsonism and Restless legs Syndrome related issues. It reports on updates of various types of Parkinsonian syndromes (e.g. Parkinson's disease, atypical, drug induced, secondary Parkinsonism, heredo-degenerative diseases) as well as other movement disorders with overlapping features. This journal also discusses developments on medical conditions known to be associated with Parkinsonism and Restless Legs Syndrome (such as sleep disorders, neuropathies, renal dysfunction, iron deficiency, pregnancy, multiple sclerosis) amongst others. It also addresses psychological, social, therapeutic, pathophysiological, etiological and genetic aspects of these disorders.
Research and Reviews in Parkinsonism will no longer consider meta-analyses for publication.
Journal metrics
Usage
5K annual downloads/views
Citation metrics
0.5 (2023) Impact Factor
1.3 (2023) 5 year IF
Understanding and using journal metrics
Journal metrics can be a useful tool for readers, as well as for authors
who are deciding where to submit their next manuscript for publication.
However, any one metric only tells a part of the story of a journal’s
quality and impact. Each metric has its limitations which means that it
should never be considered in isolation, and metrics should be used to
support and not replace qualitative review.
We strongly recommend that you always use a number of metrics, alongside
other qualitative factors such as a journal’s aims & scope, its
readership, and a review of past content published in the journal. In
addition, a single article should always be assessed on its own merits and
never based on the metrics of the journal it was published in.
Usage and acceptance rate data above are for the last full calendar year
and are updated annually in February. Speed data is updated every six
months, based on the prior six months. Citation metrics are updated
annually mid-year. Please note that some journals do not display all of
the following metrics
(find out why).
Usage:
the total number of times articles in the journal were viewed by users
of Taylor & Francis Online in the previous calendar year, rounded to the
nearest thousand.
Citation Metrics
Impact Factor*:
the average number of citations received by articles published in the
journal within a two-year window. Only journals in the Clarivate Science
Citation Index Expanded (SCIE), Social Sciences Citation Index (SSCI),
Arts and Humanities Citation Index (AHCI) and the Emerging Sources
Citation Index (ESCI) have an Impact Factor.
Impact Factor Best Quartile*:
the journal’s highest subject category ranking in the Journal Citation
Reports. Q1 = 25% of journals with the highest Impact Factors.
5 Year Impact Factor*:
the average number of citations received by articles in the journal
within a five-year window.
CiteScore (Scopus)†:
the average number of citations received by articles in the journal over
a four-year period.
CiteScore Best Quartile†:
the journal’s highest CiteScore ranking in a Scopus subject category. Q1
= 25% of journals with the highest CiteScores.
SNIP
(Source Normalized Impact per Paper):
the number of citations per paper in the journal, divided by citation
potential in the field.
SJR
(Scimago Journal Rank):
Average number of (weighted) citations in one year, divided by the
number of articles published in the journal in the previous three years.
Speed/acceptance
From submission to first decision:
the average (median) number of days for a manuscript submitted to the
journal to receive a first decision. Based on manuscripts receiving a
first decision in the last six months.
From submission to first post-review decision:
the average (median) number of days for a manuscript submitted to the
journal to receive a first decision if it is sent out for peer review.
Based on manuscripts receiving a post-review first decision in the last
six months.
From acceptance to online publication:
the average (median) number of days from acceptance of a manuscript to
online publication of the Version of Record. Based on articles published
in the last six months.
Acceptance rate:
articles accepted for publication by the journal in the previous
calendar year as percentage of all papers receiving a final decision.
Dr Peter Hedera, Department of Neurology, Vanderbilt University in Nashville, TN, United States
Editorial Board:
Professor Alberto Albanese, Department of Neurology, Humanitas Research Hospital, Milano, Italy
Professor Masharip Atadzhanov, Department of Internal Medicine, University of Zambia, Zambia
Dr Claudio L. A. Bassetti, Neurology Department, Bern University Hospital, Switzerland
Professor Thomas Davis, Neurology, Division of Movement Disorders, Vanderbilt University, Nashville, TN, United States
Dr Yuqing Li, Department of Neurology, College of Medicine, University of Florida, United States
Dr Ali Rajput, Neurology, University of Saskatchewan, Saskatoon, Canada
Dr Abdul Qayyum Rana, Parkinson’s Clinic of Eastern Toronto and Movement Disorders Centre in Toronto, Ontario, Canada
Professor Daniel Truong, past-president of the International Association for Parkinsonism and Related Disorders; Clinical Professor, University of California, Riverside, CA, USA; The Truong Neuroscience Institute, Orange Coast Memorial Medical Center, Fountain Valley, CA, USA. Editor-in-chief Journal of Clinical Parkinsonism and Related Disorders. Associate Editor: Journal of Neurological Sciences.
Dr Peter Valkovic, Second Department of Neurology, Comenius University Faculty of Medicine, Bratislava, Slovak Republic
Dr Arthur Walters, Sleep Division, Department of Neurology, United States
Dr John Woulfe, Department of Pathology and Laboratory Medicine, University of Ottawa, Canada
Dr Theresa Zesiewicz, Director of USF Ataxia Research Center, The Frances J. Zesiewicz Foundation for Parkinson's Disease at USF, Parkinson's Disease and Movement Disorders Clinic at the PADREC, Tampa, FL, United States
Open access
Research and Reviews in Parkinsonism is an open access journal and only publishes open access articles. Publishing open access means that your article will be free to access online immediately on publication, increasing the visibility, readership, and impact of your research.
Why choose open access?
Increase the discoverability and readership of your article
Make an impact and reach new readers, not just those with easy access to a research library
Freely share your work with anyone, anywhere
Comply with funding mandates and meet the requirements of your institution, employer or funder
Rigorous peer review for every open access article
Article Publishing Charges (APC)
To publish open access in this journal you may be asked to pay an Article Publishing Charge (APC). You may be able to publish your article at no cost to yourself or with a reduced APC if your institution or research funder has an open access agreement or membership with Taylor & Francis. Discounts and waivers may also be available for researchers in selected countries when publishing in open access journals.
![Sample our Medicine, Dentistry, Nursing & Allied Health journals, sign in here to start your FREE access for 14 days]({"type":"image" , "src" : "/sda/110817/Subject-Sample-2021-Medicine-Dentistry-Nursing-Allied-Health.jpg"})
![Neuro Central: Free online resource for everything neurology and neuroscience...]({"type":"image" , "src" : "/sda/112457/journalad-promotion-neurocentral.png"})